Terlipressin Infusion for Management of Post-CABG Refractory Hypotension: A Comparative Study versus Nor-epinephrine Infusion

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201705002221230

Enrollment

Registered

2017-04-21

Start date

2017-03-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circulatory System Respiratory Surgery refractory hypotension after cardiopulmonary bypass in diabetic patients

Interventions

noradrenaline infusion

Terlipressin infusion

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diabetic patients Undergoing elective CABG surgery using CPB Normal ventricular function Experience refractory hypotension after CPB

Exclusion criteria

Exclusion criteria: Emergency cardiopulmonary bypass Pripheral vascular disease Hepatic or Kidney dysfunction preoperative unstable conditions such as severe arrhythmia, heart failure or cardiogenic shock

Design outcomes

Primary

Measure	Time frame
correction of hypotension to achieve SAP>90 mmHg and/or MAP>60 mmHg.	—

Secondary

Measure	Time frame
Blood glucose levels;Evaluation of Cardiac ischemia markers (serum CK-MB and cTT)	—

Countries

Egypt

Contacts

Public ContactAhmed El-Shaarawy

lecturer of Anesthesia, Beni Suef University

drshaarawy@gmail.com00201141015584

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026